Citigroup Portfolio holdings
Citigroup is a multinational investment bank and financial services company, formed in 1998 when Citicorp, the holding company for Citibank, merged with Travelers. Citibank dates to 1812, when it was chartered as City Bank of New York to serve a group of local merchants. In 2009 it merged its Smith Barney brokerage and wealth unit with Morgan Stanley's into a joint venture, and in 2013 it sold its remaining stake to Morgan Stanley. Its businesses cover investment, corporate and commercial banking, sales and trading in the markets, cash management and trade finance for companies, wealth management, and credit cards in the United States.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$728M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$645M |
| 3 |
SPDR Gold Trust
GLD
|
+$413M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$401M |
| 5 |
SpaceX
SPCX
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.91B |
| 2 |
Micron Technology
MU
|
+$1.85B |
| 3 |
NVIDIA
NVDA
|
+$1.69B |
| 4 |
GE Vernova
GEV
|
+$809M |
| 5 |
Advanced Micro Devices
AMD
|
+$794M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.44% |
| 2 | Technology | 22.37% |
| 3 | Financials | 6.09% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Healthcare | 5.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3176
La-Z-Boy
LZB
$1.32B
| $1.08M | ﹤0.01% |
36,554
-13,349
| -27% | -$481K |
2013 Q2
53 quarters
|
|
3177
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$10B
| $1.08M | ﹤0.01% |
25,744
+23,295
| +951% | +$965K |
2020 Q4
23 quarters
|
|
3178
4D Molecular Therapeutics
FDMT
$678M
| $1.08M | ﹤0.01% |
75,204
+5,992
| +9% | +$78K |
2021 Q1
22 quarters
|
|
3179
CALL
Roivant Sciences
ROIV
$27.6B
| $1.08M | ﹤0.01% |
29,400
+2,400
| +9% | +$87K |
2025 Q3
4 quarters
|
|
|
3180
PUT
Roivant Sciences
ROIV
$27.6B
| $1.08M | ﹤0.01% |
29,400
+2,400
| +9% | +$87K |
2026 Q1
2 quarters
|
|
3181
Casella Waste Systems
CWST
$6.29B
| $1.07M | ﹤0.01% |
13,361
-24,667
| -65% | -$2.25M |
2013 Q2
53 quarters
|
|
3182
CeriBell Inc
CBLL
$1.05B
| $1.07M | ﹤0.01% |
44,014
-36,483
| -45% | -$791K |
2024 Q4
7 quarters
|
|
3183
Boston Beer
SAM
$2.32B
| $1.07M | ﹤0.01% |
6,544
-1,553
| -19% | -$275K |
2013 Q2
53 quarters
|
|
3184
SPS Commerce
SPSC
$3.02B
| $1.07M | ﹤0.01% |
13,006
-12,456
| -49% | -$924K |
2013 Q2
53 quarters
|
|
3185
State Street SPDR FactSet Innovative Technology ETF
XITK
$64M
| $1.07M | ﹤0.01% |
5,380
-81
| -1% | -$15.7K |
2023 Q2
13 quarters
|
|
3186
CALL
Solaris Energy Infrastructure
SEI
$3.79B
| $1.07M | ﹤0.01% |
15,000
-5,000
| -25% | -$305K |
2026 Q2
1 quarter
|
|
3187
Innovex International
INVX
$1.79B
| $1.07M | ﹤0.01% |
39,419
-45,059
| -53% | -$1.27M |
2013 Q2
53 quarters
|
|
3188
Enerflex
EFXT
$2.5B
| $1.06M | ﹤0.01% |
46,658
+34,713
| +291% | +$771K |
2024 Q4
7 quarters
|
|
3189
iShares MSCI USA ETF
MLRG
$1.31B
| $1.06M | ﹤0.01% |
10,056
-390
| -4% | -$41.1K |
2016 Q3
40 quarters
|
|
3190
Cadiz
CDZI
$310M
| $1.06M | ﹤0.01% |
270,956
-167,047
| -38% | -$608K |
2023 Q1
14 quarters
|
|
3191
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.28B
| $1.06M | ﹤0.01% |
5,985
+1,385
| +30% | +$248K |
2013 Q2
53 quarters
|
|
3192
Metropolitan Bank Holding Corp
MCB
$1.21B
| $1.06M | ﹤0.01% |
12,177
-4,149
| -25% | -$385K |
2017 Q4
35 quarters
|
|
3193
Northern Trust Quality Dividend Defensive ETF
QDEF
$557M
| $1.06M | ﹤0.01% |
11,904
-669
| -5% | -$60.1K |
2019 Q3
28 quarters
|
|
3194
Viridian Therapeutics
VRDN
$3.29B
| $1.06M | ﹤0.01% |
51,434
-88,981
| -63% | -$1.9M |
2021 Q4
19 quarters
|
|
3195
Innoviva
INVA
$1.54B
| $1.06M | ﹤0.01% |
49,869
-11,153
| -18% | -$237K |
2013 Q2
53 quarters
|
|
3196
PUT
Lumen Technologies, Inc. Common Stock
LUMN
$4.61B
| $1.05M | ﹤0.01% |
188,300
| – | – |
2024 Q2
9 quarters
|
|
3197
PRA Group
PRAA
$760M
| $1.05M | ﹤0.01% |
54,064
-39
| -0.1% | -$735 |
2013 Q2
53 quarters
|
|
3198
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.71B
| $1.05M | ﹤0.01% |
20,135
-1,729
| -8% | -$94.2K |
2013 Q2
53 quarters
|
|
3199
Solid Biosciences
SLDB
$699M
| $1.05M | ﹤0.01% |
145,516
-2,916
| -2% | -$26.4K |
2024 Q1
10 quarters
|
|
3200
OneSpaWorld
OSW
$3.13B
| $1.05M | ﹤0.01% |
46,633
-37,253
| -44% | -$935K |
2019 Q1
30 quarters
|
|
Similar funds
Citigroup's Q3 2026 Portfolio in Review
As of Q3 2026, Citigroup held 6,419 positions worth $308B, up 1.8% from $303B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup's Q3 2026 filing shows 741 new, 2,043 increased, 2,737 reduced and 437 closed positions. Its largest new stake was SK Hynix Inc: 1,085,406 shares worth $200M. The largest sale was Microsoft, an estimated $1.91B.
By sector, the portfolio is most concentrated in Miscellaneous at 43% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- Citigroup's largest Q3 2026 buy was SK Hynix Inc: 1,085,406 shares worth $200M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q3 2026, an estimated $728M increase.
- Citigroup's biggest Q3 2026 reduction was Microsoft, cutting an estimated $1.91B.
- Citigroup fully exited Webster Financial in Q3 2026, selling an estimated $273M.
- Citigroup's ten largest holdings make up 21% of its $308B portfolio in Q3 2026.
- Citigroup opened 741 new positions and closed 437 in Q3 2026.
- Citigroup's portfolio value rose 1.8% quarter-over-quarter to $308B.
Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.